Medicine recalls
|
| |
| Canada: Recall: Bausch Health, Canada Inc. recalls all lots of Emerade epinephrine auto-injectors (0.3 mg and 0.5 mg strengths) due to possible device failure |
| |
Bausch Health, Canada Inc. is recalling all lots of Emerade epinephrine auto-injectors (0.3 mg and 0.5 mg) after testing by the company identified the potential risk that the auto-injector may fail to activate, or it may activate prematurely if dropped.
The affected lots are:
- Emerade epinephrine auto-injectors, 0.3 mg (DIN 02458446) (Lot: Y0225B2A, Z0076B1A, Z0034B2C, Z0198B3A, Z0198B3B)
- Emerade epinephrine auto-injectors, 0.5 mg (DIN 02458454) (Lot: Y0225C1A, Z0034C1A, Z0076C2A, Z0088C3A, Z0153C2A, Z0236C1C, Z0088C3B, Z0128C1B and Z0153C2B )
Emerade auto-injectors are used to deliver an emergency treatment of epinephrine to patients who are at risk or have a history of serious allergic reactions (anaphylaxis).
Failure of the auto-injector to activate may result in patients not receiving the required dose of epinephrine, leading to the worsening of symptoms of anaphylaxis which could be life-threatening.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/bausch-health-canada-inc-recalls-all-lots-emerade-epinephrine-auto-injectors-03-mg-and#tablefield-node-73621-field_affected_products-0
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/Saturday, May 6, 2023
Issued at HKT 13:00
|
| |
|
